12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Longeveron (NASDAQ:LGVN) shares rose 7.69% to $3.64 during Monday's after-market session. The company's market cap stands at $69.5 million.
30 Stocks Moving In Monday’s Mid-Day Session
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.
RedHill Biopharma Reports Further Analysis Of Phase 2/3 Data; Reports 62% Reduction In Mortality With Oral Opaganib In Moderately Severe COVID-19 Patients
RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported new data from the opaganib global Phase 2/3 study in hospitalized
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 30)
RedHill Biopharma Files For U.S. Patent Titled ‘SERINE PROTEASE INHIBITOR FOR TREATING CORONAVIRUS INFECTION’
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=8117&p=163&f=G&l=50&d=PG01&S1=20210930.PD.&OS=PD/20210930&RS=PD/20210930
RedHill Settles Movantik Patent Litigation With Aurobindo
RedHill Biopharma Ltd (NASDAQ:RDHL) has announced a settlement and license agreement with Aurobindo Pharma USA Inc resolving their patent litigation in the U.S.…
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 20)
TENX: Second Quarter Results
By John Vandermosten, CFA
NASDAQ:TENX
READ THE FULL TENX RESEARCH REPORT
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 14)